Publications by authors named "Alan Gradman"

Claim this Profile
A
Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension.
Jack Ishak, Michael Rael, Henry Punzi, Alan Gradman, Lynn M Anderson

J Clin Hypertens (Greenwich)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Elusive Search for Optimal Blood Pressure Targets.
Alan H Gradman

Curr Hypertens Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quarter-dose quadpill for initial treatment of hypertension.
Alan H Gradman

Lancet· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure target values: the saga continues.
Alan H Gradman

Eur Heart J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPRINT: To Whom Do the Results Apply?
Alan H Gradman

J Am Coll Cardiol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple Stakeholders.
David S Kountz, Fadia T Shaya, Alan H Gradman, Gary A Puckrein, Michael H Kim

J Manag Care Spec Pharm· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on "is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database".
Alan H Gradman, Francis Vekeman, Adi Eldar-Lissai, Alex Trahey, Mei Sheng Duh

J Card Fail· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LCZ696: the next step in improving RAS inhibition?
Alan H Gradman

Curr Hypertens Rep· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database.
Alan H Gradman, Francis Vekeman, Adi Eldar-Lissai, Alex Trahey, Siew Hwa Ong

J Card Fail· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent clinical trials.
Alan H Gradman, Jan N Basile

J Am Soc Hypertens· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal blood pressure targets in older adults: how low is low enough?
Alan H Gradman

J Am Coll Cardiol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Thomas D Giles, Michael A Weber, Jan Basile, Alan H Gradman, David B Bharucha

Lancet· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study.
Alan H Gradman, Hélène Parisé, Patrick Lefebvre, Heather Falvey, Marie-Hélène Lafeuille

Hypertension· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for combination therapy in hypertension.
Alan H Gradman

Curr Opin Nephrol Hypertens· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
Domenic Sica, Alan H Gradman, Ole Lederballe, Rainer E Kolloch, Jack Zhang

Clin Drug Investig· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies.
Vasilios Papademetriou, Konstantinos Tsioufis, Alan Gradman, Henry Punzi

Int J Hypertens· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep-time blood pressure: a validated therapeutic target.
Alan H Gradman

J Am Coll Cardiol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal nerve ablation for resistant hypertension.
Alan H Gradman

Curr Hypertens Rep· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy in hypertension.
Alan H Gradman, Jan N Basile, Barry L Carter, George L Bakris,

J Clin Hypertens (Greenwich)· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale for triple-combination therapy for management of high blood pressure.
Alan H Gradman

J Clin Hypertens (Greenwich)· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy in hypertension.
Alan H Gradman, Jan N Basile, Barry L Carter, George L Bakris, Barry J Materson

J Am Soc Hypertens· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy in hypertension.
Alan H Gradman, Jan N Basile, Barry L Carter, George L Bakris,

J Am Soc Hypertens· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leadership message. Maintaining core values.
Alan H Gradman

J Clin Hypertens (Greenwich)· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.
Alice V Stanton, Alan H Gradman, Roland E Schmieder, Juerg Nussberger, Ramesh Sarangapani

Hypertension· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
Alan H Gradman, Vasilios Papademetriou

Am Heart J· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis